Pharma channel feed

Genen­tech is Broad­way bound with lat­est cam­paign to raise spinal mus­cu­lar at­ro­phy aware­ness

Last year
Marketing

House com­mit­tee ad­vances an­oth­er PBM re­form bill that would ban spread pric­ing

Last year
FDA+

As obe­si­ty mar­ket heats up, Am­gen leaves clues on Mar­i­Tide’s path for­ward

Last year

Up­dat­ed: Bridge­Bio inks $100M up­front deal with Ky­owa Kirin for skele­tal dis­or­der drug

Last year
Deals

Gilead won't ac­quire check­point on­col­o­gy biotech Tizona

Last year
Deals

Lil­ly to build man­u­fac­tur­ing ca­pac­i­ty at risk to pre­pare for next-gen oral obe­si­ty drug

Last year
Manufacturing

Gilead em­pha­sizes in­equities in HIV, hep C and can­cer through 'mar­gin' book project

Last year
Marketing

Law­mak­ers hold FDA for­eign in­spec­tion prac­tices un­der mi­cro­scope at hear­ing with­out agency at­ten­dance

Last year
FDA+
Manufacturing

Will an up­com­ing Sen­ate hear­ing help low­er drug prices? It de­pends who you ask

Last year
FDA+

Uni­ver­si­ties de­cry Biden's plan for 'march-in' rights as dis­in­cen­tiviz­ing bio­phar­ma part­ner­ships

Last year
Law

J&J em­ploy­ee sues com­pa­ny over al­leged mis­man­age­ment of pre­scrip­tion drug pro­gram

Last year
Law

Mar­ket­ingRx roundup: Phar­ma mar­keters grab screen time at Gram­my Awards; Boehringer adds new Jar­diance TV ad

Last year
Marketing

Phar­ma ads get caught by stricter Meta en­force­ment in elec­tion year

Last year
Marketing

With sub­par sales for Leqem­bi, Ei­sai de­lays Alzheimer’s pa­tient goal dead­line

Last year

Lil­ly ax­es PhI­II tri­al of Verzenio in prostate can­cer

Last year
R&D

Lil­ly's weight loss drug Zep­bound gen­er­ates $175M with­in weeks as Moun­jaro sales al­so soar

Last year

Ver­tex un­veils cys­tic fi­bro­sis da­ta, talks of us­ing pri­or­i­ty re­view vouch­er

Last year
FDA+

No­var­tis to buy Mor­phoSys for $2.9B af­ter 20 years of cre­at­ing an­ti­bod­ies with the Ger­man biotech

Last year
Deals

Van­da takes is­sue with FDA's re­lay of de­fi­cien­cies for new Het­lioz in­di­ca­tion

Last year
FDA+

Mak­ers of block­buster weight loss drugs are us­ing 'patent thick­et­s' to pro­tect prod­ucts, Har­vard study claims

Last year
FDA+

Up­dat­ed: Astel­las low­ers sales ex­pec­ta­tions for menopause drug, aims to ‘re­pro­duce’ hype for Veozah with an­oth­er Su­per Bowl ad

Last year
Marketing

New Te­va ad cam­paign fo­cus­es on pa­tients strug­gling with psy­chi­atric drug side ef­fect

Last year
Marketing

Fed­er­al judge toss­es out an­titrust law­suit against Eli Lil­ly, Sanofi over di­a­betes drug dis­counts

Last year
Law

Amer­i­can Bar As­so­ci­a­tion says low­er court was 'ill-equipped' to re­strict abor­tion pill use

Last year
FDA+
Law
First page Previous page 72737475767778 Next page Last page
A service from the Financial Times